#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Colorectal cancer metastatic Obesity Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Crigler-Najjar syndrome Pemphigus Granulomatosis with polyangiitis Neuroendocrine carcinoma MELAS syndrome Acquired haemophilia Cardiac failure acute Waldenstrom's macroglobulinaemia recurrent Autologous haematopoietic stem cell transplant Antiphospholipid antibodies Cluster headache Friedreich's ataxia Herpes simplex Neuropathy peripheral Small intestine neuroendocrine tumour More trials…

    Learn about Rare Diseases

    Chondrosarcoma metastatic Congenital hypotransferrinaemia – Life with Disease Piriformis syndrome – Diagnostics Marginal zone lymphoma – Trials in Disease Glycogen storage disease type I Propionic acidaemia – Life with Disease Mantle cell lymphoma refractory – Trials in Disease Mucopolysaccharidosis II – Diagnostics Nodal marginal zone B-cell lymphoma – Diagnostics Lymphatic malformation – Trials in Disease More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    AGALSIDASE BETA Everolimus Gs-5718-03 Tucidinostat Clenbuterol Hydrochloride Autologous Chondrocytes Dexketoprofen Trometamol Apraglutide Atazanavir Thiamazole Gskvx000000014593 Magnesium Sulfate Enzalutamide Enomimeran Darbepoetin Alfa Beclometasone Dipropionate Camphor Valganciclovir Enpatoran Elezanumab More therapies…

    Learn about Your Condition

    Liposarcoma metastatic Actinic cheilitis Pharyngeal cancer stage I Osteotomy Herpes simplex Bone metabolism disorder Immunodeficiency Glomerulonephritis Idiopathic pulmonary fibrosis Progressive supranuclear palsy Non-Hodgkin's lymphoma Lymphocytic leukaemia Pulmonary embolism Bone marrow disorder Non-obstructive cardiomyopathy More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Digestive System Diseases

  • Study on the Effectiveness of Paclitaxel and Gemcitabine for Patients with Pancreatic Cancer Spread to the Abdomen

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Pancreatic carcinoma
    Investigated Drugs:
    • Gemcitabine
    • Paclitaxel
    Italy

  • Study of esomeprazole effects on endoscopic sleeve gastroplasty structural integrity in obese patients

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Obesity
    Investigated Drugs:
    • Esomeprazole
    Italy

  • Study on Recurrent Colorectal Liver Metastases: Evaluating Calcium Folinate, Fluorouracil, Capecitabine, Oxaliplatin, and Irinotecan in a Drug Combination for Eligible Patients

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Colorectal cancer
    Investigated Drugs:
    • Irinotecan Hydrochloride Trihydrate
    • Calcium Folinate Pentahydrate
    • Capecitabine
    The Netherlands

  • Study of Ginisortamab with Nab-Paclitaxel and Gemcitabine or MEK Inhibitor for Patients with Metastatic Pancreatic Cancer

    Recruiting

    2 1 1 1
    Investigated Drugs:
    • Ginisortamab
    • Cobimetinib
    Germany Norway Spain

  • Study on Norfloxacin for Reducing Portal Hypertension in Patients with Decompensated Cirrhosis

    Recruiting

    2 1 1
    Investigated Diseases:
    • Portal hypertension
    • Hepatic cirrhosis
    Investigated Drugs:
    • Norfloxacin
    Austria

  • Study on Pre-Operative Chemotherapy with Disodium Folinate, Oxaliplatin, and Fluorouracil for Patients with Advanced Resectable Colon Cancer

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Colon cancer stage III
    • Colon cancer stage IV
    Investigated Drugs:
    • Disodium Folinate
    • Calcium Folinate
    • Capecitabine
    Germany
Previous Page
1 … 17 18 19 20 21 … 93
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!